Pay in 4 interest-free payments of $6.37 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Enclomiphene: Phase III trial data (Wiehle et al.) reported headache and nausea at low rates
This slowdown results in a feeling of satiety, a reduction in food intake and a more controlled release of glucose into the bloodstream to then avoid a sudden glucose spike
The most clinically significant interaction involves other glucose-lowering medications, particularly insulin and sulfonylureas (such as gliclazide)
The Goals of Treatment for Type 2 Diabetes: Treat the Patient, Not Just the A1c
US$ 27.31
US$ 21.30
US$ 25.26
US$ 21.03
US$ 23.18
US$ 25.00
US$ 24.28
US$ 26.30
